These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22308085)

  • 1. Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation.
    Scridon A; Morel E; Nonin-Babary E; Girerd N; Fernandez C; Chevalier P
    Europace; 2012 Jul; 14(7):948-53. PubMed ID: 22308085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Source of inflammatory markers in patients with atrial fibrillation.
    Liuba I; Ahlmroth H; Jonasson L; Englund A; Jönsson A; Säfström K; Walfridsson H
    Europace; 2008 Jul; 10(7):848-53. PubMed ID: 18523031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients.
    Scridon A; Girerd N; Rugeri L; Nonin-Babary E; Chevalier P
    Europace; 2013 Nov; 15(11):1562-6. PubMed ID: 23689486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation.
    De Gennaro L; Brunetti ND; Montrone D; De Rosa F; Cuculo A; Di Biase M
    Eur J Clin Invest; 2012 Apr; 42(4):371-5. PubMed ID: 21913917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation.
    Shimano M; Inden Y; Tsuji Y; Kamiya H; Uchikawa T; Shibata R; Murohara T
    Europace; 2008 Aug; 10(8):961-6. PubMed ID: 18550508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients.
    Kaireviciute D; Blann AD; Balakrishnan B; Lane DA; Patel JV; Uzdavinys G; Norkunas G; Kalinauskas G; Sirvydis V; Aidietis A; Lip GY
    Thromb Haemost; 2010 Jul; 104(1):122-7. PubMed ID: 20458440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High concentrations of B-type natriuretic peptide and left ventricular diastolic dysfunction in patients with paroxysmal/persistent atrial fibrillation as possible markers of conversion into permanent form of arrhythmia: 1-year prospective evaluation.
    Dabrowski R; Borowiec A; Janas J; Firek B; Kowalik I; Smolis-Bak E; Luczak D; Sosnowski C; Kazimierska B; Szwed H
    Kardiol Pol; 2010 Aug; 68(8):893-900. PubMed ID: 20730719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide?
    Goette A; Jentsch-Ullrich K; Lendeckel U; Röcken C; Agbaria M; Auricchio A; Mohren M; Franke A; Klein HU
    Circulation; 2003 Nov; 108(20):2446-9. PubMed ID: 14610014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis.
    Watson T; Shantsila E; Blann A; Lip GY
    Thromb Haemost; 2010 Aug; 104(2):327-34. PubMed ID: 20508899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Herman Z; Kosior D
    Cardiol J; 2008; 15(6):525-9. PubMed ID: 19039756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure.
    On YK; Jeon ES; Lee SY; Shin DH; Choi JO; Sung J; Kim JS; Sung K; Park P
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1515-20. PubMed ID: 19464473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex electrograms within the coronary sinus: time- and frequency-domain characteristics, effects of antral pulmonary vein isolation, and relationship to clinical outcome in patients with paroxysmal and persistent atrial fibrillation.
    Yoshida K; Ulfarsson M; Tada H; Chugh A; Good E; Kuhne M; Crawford T; Sarrazin JF; Chalfoun N; Wells D; Jongnarangsin K; Pelosi F; Bogun F; Morady F; Oral H
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1017-23. PubMed ID: 18462334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting.
    Ishida K; Kimura F; Imamaki M; Ishida A; Shimura H; Kohno H; Sakurai M; Miyazaki M
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):501-5. PubMed ID: 16439145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Termination of long-lasting persistent versus short-lasting persistent and paroxysmal atrial fibrillation by ablation.
    Fiala M; Chovancík J; Nevralová R; Neuwirth R; Jiravský O; Januska J; Branny M
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):985-97. PubMed ID: 18684255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines.
    Cheng T; Wang XF; Hou YT; Zhang L
    Mol Med Rep; 2012 Sep; 6(3):581-4. PubMed ID: 22684635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Arfanakis DA; Maliaraki NE; Lathourakis CE; Chlouverakis GI; Vardas PE
    J Am Coll Cardiol; 2008 Jul; 52(3):211-5. PubMed ID: 18617070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
    Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
    Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory markers according to types of atrial fibrillation.
    Gedikli O; Dogan A; Altuntas I; Altinbas A; Ozaydin M; Akturk O; Acar G
    Int J Cardiol; 2007 Aug; 120(2):193-7. PubMed ID: 17240468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
    Conway DS; Buggins P; Hughes E; Lip GY
    J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cytokine concentrations following successful ablation of atrial fibrillation.
    Osmancik P; Peroutka Z; Budera P; Herman D; Stros P; Straka Z
    Eur Cytokine Netw; 2010 Dec; 21(4):278-84. PubMed ID: 21106468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.